A new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) says that a molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat the most frequent and lethal form of brain cancer. The findings, published in the journal iCancer Research/i, show that high levels of the enzyme PRMT5 are ...
Read More
No comments:
Post a Comment